Pfizer, Bourla and obesity
Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head-on.
Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...
Sasanlimab, a subcutaneous immunotherapy developed by Pfizer, could help treat bladder cancer. Elsewhere, Royalty Pharma ...
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...
17hon MSN
The Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiation targets, a list of 15 ...
Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback